31763180|t|Neuroprotective potential of solanesol in intracerebroventricular propionic acid induced experimental model of autism: Insights from behavioral and biochemical evidence.
31763180|a|Autism is the category used within the newest edition of the diagnostic and statistical manual of neurodevelopmental disorders. Autism is a spectrum of disorder where a variety of behavioural patterns observed in autistic patients, such as stereotypes and repetitive behavior, hyperexcitability, depression-like symptoms, and memory and cognitive dysfunctions. Neuropathological hallmarks that associated with autism are mitochondrial dysfunction, oxidative stress, neuroinflammation, Neuro-excitation, abnormal synapse formation, overexpression of glial cells in specific brain regions like cerebellum, cerebral cortex, amygdala, and hippocampus. ICV injection of propionic acid (PPA) (4 mul/0.26 M) mimics autistic-like behavioral and biochemical alterations in rats. Literature findings reveal that there is a link between autism neuronal mitochondrial coenzyme-Q10 (CoQ10) and ETC-complexes dysfunctions are the keys pathogenic events for autism. Therefore, in the current study, we explore the neuroprotective interventions of Solanesol (SNL) 40 and 60 mg/kg alone and in combination with standard drugs Aripiprazole (ARP) 5 mg/kg, Citalopram (CTP) 10 mg/kg, Memantine (MEM) 5 mg/kg and Donepezil (DNP) 3 mg/kg to overcome behavioral and biochemical alterations in PPA induced experimental model of Autism. Chronic treatment with SNL 60 mg/kg in combination with standard drug shows a marked improvement in locomotion, muscle coordination, long-term memory and the decrease in depressive behavior. While, chronic treatment of SNL alone and in combination with standard drug aripiprazole, citalopram, donepezil, and memantine shows the Neuroprotective potential by enhancing the cognitive deficits, biochemical alterations along with reducing the level of inflammatory mediators and oxidative stress.
31763180	29	38	solanesol	Chemical	MESH:C017719
31763180	66	80	propionic acid	Chemical	MESH:C029658
31763180	111	117	autism	Disease	MESH:D001321
31763180	170	176	Autism	Disease	MESH:D001321
31763180	268	296	neurodevelopmental disorders	Disease	MESH:D002658
31763180	298	304	Autism	Disease	MESH:D001321
31763180	383	391	autistic	Disease	MESH:D001321
31763180	392	400	patients	Species	9606
31763180	426	445	repetitive behavior	Disease	MESH:D001523
31763180	447	464	hyperexcitability	Disease	
31763180	466	476	depression	Disease	MESH:D003866
31763180	477	481	like	Disease	MESH:C537419
31763180	496	529	memory and cognitive dysfunctions	Disease	MESH:D003072
31763180	580	586	autism	Disease	MESH:D001321
31763180	591	616	mitochondrial dysfunction	Disease	MESH:D028361
31763180	636	653	neuroinflammation	Disease	MESH:D000090862
31763180	757	761	like	Disease	MESH:C537419
31763180	835	849	propionic acid	Chemical	MESH:C029658
31763180	851	854	PPA	Chemical	MESH:C029658
31763180	878	886	autistic	Disease	MESH:D001321
31763180	887	891	like	Disease	MESH:C537419
31763180	934	938	rats	Species	10116
31763180	996	1002	autism	Disease	MESH:D001321
31763180	1026	1038	coenzyme-Q10	Chemical	MESH:C024989
31763180	1040	1045	CoQ10	Chemical	MESH:C024989
31763180	1113	1119	autism	Disease	MESH:D001321
31763180	1202	1211	Solanesol	Chemical	MESH:C017719
31763180	1213	1216	SNL	Chemical	MESH:C017719
31763180	1279	1291	Aripiprazole	Chemical	MESH:D000068180
31763180	1293	1296	ARP	Chemical	MESH:D000068180
31763180	1307	1317	Citalopram	Chemical	MESH:D015283
31763180	1319	1322	CTP	Chemical	MESH:D015283
31763180	1334	1343	Memantine	Chemical	MESH:D008559
31763180	1362	1371	Donepezil	Chemical	MESH:D000077265
31763180	1373	1376	DNP	Chemical	MESH:D000077265
31763180	1440	1443	PPA	Chemical	MESH:C029658
31763180	1474	1480	Autism	Disease	MESH:D001321
31763180	1505	1508	SNL	Chemical	MESH:C017719
31763180	1652	1662	depressive	Disease	MESH:D003866
31763180	1701	1704	SNL	Chemical	MESH:C017719
31763180	1749	1761	aripiprazole	Chemical	MESH:D000068180
31763180	1763	1773	citalopram	Chemical	MESH:D015283
31763180	1775	1784	donepezil	Chemical	MESH:D000077265
31763180	1790	1799	memantine	Chemical	MESH:D008559
31763180	1853	1871	cognitive deficits	Disease	MESH:D003072
31763180	1930	1942	inflammatory	Disease	MESH:D007249
31763180	Negative_Correlation	MESH:D000077265	MESH:D001321
31763180	Positive_Correlation	MESH:D015283	MESH:D003072
31763180	Negative_Correlation	MESH:D008559	MESH:D001321
31763180	Negative_Correlation	MESH:D000077265	MESH:D007249
31763180	Positive_Correlation	MESH:C024989	MESH:D001321
31763180	Negative_Correlation	MESH:D000068180	MESH:D007249
31763180	Negative_Correlation	MESH:C017719	MESH:C029658
31763180	Negative_Correlation	MESH:C017719	MESH:D007249
31763180	Positive_Correlation	MESH:D000068180	MESH:D003072
31763180	Negative_Correlation	MESH:C017719	MESH:D001321
31763180	Comparison	MESH:C017719	MESH:D000077265
31763180	Cotreatment	MESH:C017719	MESH:D008559
31763180	Association	MESH:D000077265	MESH:D003072
31763180	Negative_Correlation	MESH:C017719	MESH:D003866
31763180	Cotreatment	MESH:C017719	MESH:D000068180
31763180	Cotreatment	MESH:C017719	MESH:D015283
31763180	Negative_Correlation	MESH:D015283	MESH:D007249
31763180	Negative_Correlation	MESH:D015283	MESH:D001321
31763180	Positive_Correlation	MESH:D008559	MESH:D003072
31763180	Association	MESH:C024989	MESH:C029658
31763180	Positive_Correlation	MESH:C017719	MESH:D003072
31763180	Positive_Correlation	MESH:C029658	MESH:D001321
31763180	Positive_Correlation	MESH:C029658	MESH:C537419
31763180	Negative_Correlation	MESH:D008559	MESH:D007249

